癌变
睡美人转座系统
肝细胞癌
肝癌
体内
癌症研究
转座因子
发病机制
肝组织
癌症
医学
生物信息学
生物
基因
病理
遗传学
内科学
基因组
作者
Lingli He,Wentao Yu,Yi Lu,Wenxiang Zhang,Jinjin Xu,Lei Zhang
出处
期刊:STAR protocols
[Elsevier BV]
日期:2021-04-09
卷期号:2 (2): 100445-100445
被引量:3
标识
DOI:10.1016/j.xpro.2021.100445
摘要
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide. However, the pathogenesis of HCC is complicated, and the drugs used for HCC treatment are limited. The following protocol combines a genetically engineered mouse model (GEMM) with a sleeping beauty system to establish an in vivo liver tumorigenesis model. By using this model, the impact of genes of interest in liver tumorigenesis and progression can be studied. This model can also be applied to develop new therapeutic drugs for HCC. For complete details on the use and execution of this protocol, please refer to He et al. (2020).
科研通智能强力驱动
Strongly Powered by AbleSci AI